The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease. (7th September 2021)
- Record Type:
- Journal Article
- Title:
- The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease. (7th September 2021)
- Main Title:
- The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease
- Authors:
- Bourgonje, Arno R
Hu, Shixian
Spekhorst, Lieke M
Zhernakova, Daria V
Vich Vila, Arnau
Li, Yanni
Voskuil, Michiel D
van Berkel, Lisette A
Bley Folly, Brenda
Charrout, Mohammed
Mahfouz, Ahmed
Reinders, Marcel J T
van Heck, Julia I P
Joosten, Leo A B
Visschedijk, Marijn C
van Dullemen, Hendrik M
Faber, Klaas Nico
Samsom, Janneke N
Festen, Eleonora A M
Dijkstra, Gerard
Weersma, Rinse K - Abstract:
- Abstract: Background and Aims: Protein profiling in patients with inflammatory bowel diseases [IBD] for diagnostic and therapeutic purposes is underexplored. This study analysed the association between phenotype, genotype, and the plasma proteome in IBD. Methods: A total of 92 inflammation-related proteins were quantified in plasma of 1028 patients with IBD (567 Crohn's disease [CD]; 461 ulcerative colitis [UC]) and 148 healthy individuals to assess protein-phenotype associations. Corresponding whole-exome sequencing and global screening array data of 919 patients with IBD were included to analyse the effect of genetics on protein levels (protein quantitative trait loci [pQTL] analysis). Intestinal mucosal RNA sequencing and faecal metagenomic data were used for complementary analyses. Results: Thirty-two proteins were differentially abundant between IBD and healthy individuals, of which 22 proteins were independent of active inflammation; 69 proteins were associated with 15 demographic and clinical factors. Fibroblast growth factor-19 levels were decreased in CD patients with ileal disease or a history of ileocecal resection. Thirteen novel cis -pQTLs were identified and 10 replicated from previous studies. One trans -pQTL of the fucosyltransferase 2 [ FUT2 ] gene [rs602662] and two independent cis -pQTLs of C-C motif chemokine 25 [ CCL25 ] affected plasma CCL25 levels. Intestinal gene expression data revealed an overlapping cis -expression [e]QTL-variant [rs3745387] of theAbstract: Background and Aims: Protein profiling in patients with inflammatory bowel diseases [IBD] for diagnostic and therapeutic purposes is underexplored. This study analysed the association between phenotype, genotype, and the plasma proteome in IBD. Methods: A total of 92 inflammation-related proteins were quantified in plasma of 1028 patients with IBD (567 Crohn's disease [CD]; 461 ulcerative colitis [UC]) and 148 healthy individuals to assess protein-phenotype associations. Corresponding whole-exome sequencing and global screening array data of 919 patients with IBD were included to analyse the effect of genetics on protein levels (protein quantitative trait loci [pQTL] analysis). Intestinal mucosal RNA sequencing and faecal metagenomic data were used for complementary analyses. Results: Thirty-two proteins were differentially abundant between IBD and healthy individuals, of which 22 proteins were independent of active inflammation; 69 proteins were associated with 15 demographic and clinical factors. Fibroblast growth factor-19 levels were decreased in CD patients with ileal disease or a history of ileocecal resection. Thirteen novel cis -pQTLs were identified and 10 replicated from previous studies. One trans -pQTL of the fucosyltransferase 2 [ FUT2 ] gene [rs602662] and two independent cis -pQTLs of C-C motif chemokine 25 [ CCL25 ] affected plasma CCL25 levels. Intestinal gene expression data revealed an overlapping cis -expression [e]QTL-variant [rs3745387] of the CCL25 gene. The FUT2 rs602662 trans -pQTL was associated with reduced abundances of faecal butyrate-producing bacteria. Conclusions: This study shows that genotype and multiple disease phenotypes strongly associate with the plasma inflammatory proteome in IBD, and identifies disease-associated pathways that may help to improve disease management in the future. … (more)
- Is Part Of:
- Journal of Crohn's and colitis. Volume 16:Number 3(2022)
- Journal:
- Journal of Crohn's and colitis
- Issue:
- Volume 16:Number 3(2022)
- Issue Display:
- Volume 16, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 16
- Issue:
- 3
- Issue Sort Value:
- 2022-0016-0003-0000
- Page Start:
- 414
- Page End:
- 429
- Publication Date:
- 2021-09-07
- Subjects:
- Inflammatory bowel disease -- genetics -- proteomics
Inflammatory bowel diseases -- Periodicals
616.344005 - Journal URLs:
- http://www.journals.elsevier.com/journal-of-crohns-and-colitis/ ↗
http://ecco-jcc.oxfordjournals.org/content/9/3 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1093/ecco-jcc/jjab157 ↗
- Languages:
- English
- ISSNs:
- 1873-9946
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4965.651500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 20745.xml